Soleilmane Omarjee

Biochemistry, Genetics and Molecular Biology · Life Sciences

11h-index844citations62works0.42yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Estrogen and related hormone effects(22), Genomics, phytochemicals, and oxidative stress(10), HER2/EGFR in Cancer Research(8), Click Chemistry and Applications(8), Genomics and Chromatin Dynamics(6)

Publications62 total

Supplementary Figures 1-8 from FOXA1 Reprogramming Dictates Retinoid X Receptor Response in <i>ESR1</i>-Mutant Breast Cancer
2025Open Access
Supplementary Tables 1-5 from FOXA1 Reprogramming Dictates Retinoid X Receptor Response in <i>ESR1</i>-Mutant Breast Cancer
2025Open Access
The EstroGene2.0 database for endocrine therapy response and resistance in breast cancer
npj Breast Cancer·2024· 2 citedOpen Access
Data from FOXA1 reprogramming dictates retinoid X receptor response in ESR1 mutant breast cancer
2024Open Access
Supplementary Tables 1-5 from FOXA1 reprogramming dictates retinoid X receptor response in ESR1 mutant breast cancer
2024Open Access
Supplementary Figures 1-8 from FOXA1 reprogramming dictates retinoid X receptor response in ESR1 mutant breast cancer
2024Open Access
Supplementary Tables 1-5 from FOXA1 reprogramming dictates retinoid X receptor response in ESR1 mutant breast cancer
2024Open Access
Supplementary Figures 1-8 from FOXA1 reprogramming dictates retinoid X receptor response in ESR1 mutant breast cancer
2024Open Access
EstroGene2.0: A multi-omic database of response to estrogens, ER-modulators, and resistance to endocrine therapies in breast cancer
2024· 2 citedOpen Access
Inhibition of AR and DNA-PK for radio-sensitization of AR-driven cancers.
Journal of Clinical Oncology·2024
TRIB1 modulates transcriptional programming in breast cancer cells to regulate cell proliferation
2023· 1 citedOpen Access
Data from FOXA1 Reprogramming Dictates Retinoid X Receptor Response in <i>ESR1</i>-Mutant Breast Cancer
2023Open Access
Supplementary Tables 1-5 from FOXA1 Reprogramming Dictates Retinoid X Receptor Response in <i>ESR1</i>-Mutant Breast Cancer
2023Open Access
Supplementary Figures 1-8 from FOXA1 Reprogramming Dictates Retinoid X Receptor Response in <i>ESR1</i>-Mutant Breast Cancer
2023Open Access
Supplementary Tables 1-5 from FOXA1 Reprogramming Dictates Retinoid X Receptor Response in <i>ESR1</i>-Mutant Breast Cancer
2023Open Access
Supplementary Figures 1-8 from FOXA1 Reprogramming Dictates Retinoid X Receptor Response in <i>ESR1</i>-Mutant Breast Cancer
2023Open Access
Supplementary Figures 1-8 from FOXA1 Reprogramming Dictates Retinoid X Receptor Response in <i>ESR1</i>-Mutant Breast Cancer
2023Open Access
Supplementary Tables 1-5 from FOXA1 Reprogramming Dictates Retinoid X Receptor Response in <i>ESR1</i>-Mutant Breast Cancer
2023Open Access
Data from FOXA1 Reprogramming Dictates Retinoid X Receptor Response in <i>ESR1</i>-Mutant Breast Cancer
2023Open Access
Data from FOXA1 Reprogramming Dictates Retinoid X Receptor Response in <i>ESR1</i>-Mutant Breast Cancer
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Jason S. Carroll(27), Isabelle Treilleux(21), Loay Kassem(18), Zheqi Li(16), Adrian V. Lee(16), Steffi Oesterreich(16), Adrien Nougarède(15), Nikolay Popgeorgiev(15), Stéphane Borel(15), Ivan Mikaélian(15), Jonathan Lopez(15), Rudy Gadet(15), Olivier Marcillat(15), Bruno O. Villoutreix(15), Ruth Rimokh(15), Germain Gillet(15), Jason Gertz(15), Yang Wu(14), Abdalla M. Wedn(14), Allison N. Casey(14)